Insights

Innovative Technology Nabsys offers a cutting-edge electronic genome mapping platform, OhmX, with high resolution detection capabilities and simplified workflows, making it an attractive solution for genomics labs seeking advanced SV analysis at a lower cost.

Market Expansion Recent strategic partnerships and distribution agreements, particularly in Canada, position Nabsys to rapidly expand its footprint in North America and capitalize on growing demand for innovative genome mapping technologies.

Targeted Customer Base Nabsys’s platform is designed for research institutions, clinical labs, and biotech companies focused on structural variant analysis, presenting opportunities for sales in genomics research, genetic diagnostics, and personalized medicine sectors.

Upcoming Events Active participation in major conferences like ASHG 2025 provides opportunities to showcase the platform to key decision-makers and establish direct relationships with potential clients and collaborators.

Growth Potential With recent product launches and a dedicated sales leadership team, Nabsys is well-positioned for commercial growth, offering prospects for expanding existing customer accounts and onboarding new clients seeking high-resolution genome analysis solutions.

Nabsys Tech Stack

Nabsys uses 8 technology products and services including HubSpot Analytics, Open Graph, Salesforce, and more. Explore Nabsys's tech stack below.

  • HubSpot Analytics
    Analytics
  • Open Graph
    Content Management System
  • Salesforce
    Customer Relationship Management
  • Font Awesome
    Font Scripts
  • jQuery
    Javascript Libraries
  • HubSpot
    Marketing Automation
  • X-XSS-Protection
    Security
  • X-Content-Type-Options
    Web & Portal Technology

Media & News

Nabsys's Email Address Formats

Nabsys uses at least 1 format(s):
Nabsys Email FormatsExamplePercentage
Last@nabsys.comDoe@nabsys.com
89%
FLast@nabsys.comJDoe@nabsys.com
6%
First.Last@nabsys.comJohn.Doe@nabsys.com
3%
FirstLast@nabsys.comJohnDoe@nabsys.com
2%

Frequently Asked Questions

Where is Nabsys's headquarters located?

Minus sign iconPlus sign icon
Nabsys's main headquarters is located at 60 Clifford St, Providence, RI 02903, US. The company has employees across 2 continents, including North AmericaAsia.

What is Nabsys's phone number?

Minus sign iconPlus sign icon
You can contact Nabsys's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Nabsys's official website and social media links?

Minus sign iconPlus sign icon
Nabsys's official website is nabsys.com and has social profiles on LinkedInCrunchbase.

How much revenue does Nabsys generate?

Minus sign iconPlus sign icon
As of October 2025, Nabsys's annual revenue is estimated to be $9M.

What is Nabsys's SIC code NAICS code?

Minus sign iconPlus sign icon
Nabsys's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Nabsys have currently?

Minus sign iconPlus sign icon
As of October 2025, Nabsys has approximately 72 employees across 2 continents, including North AmericaAsia. Key team members include Chief Operating Officer: R. L.Chief Financial Officer: S. M.Founder & Ceo: B. B.. Explore Nabsys's employee directory with LeadIQ.

What industry does Nabsys belong to?

Minus sign iconPlus sign icon
Nabsys operates in the Biotechnology Research industry.

What technology does Nabsys use?

Minus sign iconPlus sign icon
Nabsys's tech stack includes HubSpot AnalyticsOpen GraphSalesforceFont AwesomejQueryHubSpotX-XSS-ProtectionX-Content-Type-Options.

What is Nabsys's email format?

Minus sign iconPlus sign icon
Nabsys's email format typically follows the pattern of Last@nabsys.com. Find more Nabsys email formats with LeadIQ.

How much funding has Nabsys raised to date?

Minus sign iconPlus sign icon
As of October 2025, Nabsys has raised $13M in funding. The last funding round occurred on Nov 09, 2022 for $13M.
Nabsys

Nabsys

Biotechnology ResearchUnited States51-200 Employees

Electronic Genome Mapping
Setting a new standard in structural variant analysis

Nabsys, the pioneer of electronic genome mapping (EGM), uses solid-state nanodetectors to survey long DNA molecules to construct high-density maps with long-range information required to detect structural variants (SVs). Unlike other DNA mapping technologies that rely on the use of expensive optical imaging or fluorescent labels whose resolution is inherently limited by light diffraction, EGM identifies tags in close proximity therebye producing superior resolution. This high-density information makes it possible to identify both balanced and unbalanced SVs as small as 300 bp, in addition to larger chromosomal aberrations and genetic variation missed by next-generation sequencing. EGM involves simple, intuitive workflows eliminating the need for cytogenetics technical expertise, while delivering on the promise of easy-to-use, accurate, low-cost, whole-genome SV analysis.

Visit the new Nabsys: https://nabsys.com/


Meet the OhmX™ Platform: Explore the genome in high-resolution.

From sample prep through analysis, the OhmX end-to-end solution allows you to detect balanced and unbalanced events and a broad range of structural variants with precision. 

High Resolution
Detection of SVs as small as 300 bp with >100 kb read lengths

Low Cost
Low instrument and consumable costs compared to other technologies

Small Footprint
Entire platform fits within 30"x17" saving valuable benchtop space

Easy to Operate
Easy sample prep, automated run monitoring & minimal hands-on time

Accessible Analytics 
Web-based UI for data mining SVs via Human Chromosome Explorer™ powered by Hitachi High Tech

Section iconCompany Overview

Headquarters
60 Clifford St, Providence, RI 02903, US
Phone number
Website
nabsys.com
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Employees
51-200

Section iconFunding & Financials

  • $13M

    Nabsys has raised a total of $13M of funding over 9 rounds. Their latest funding round was raised on Nov 09, 2022 in the amount of $13M.

  • $25M$50M

    Nabsys's revenue is estimated to be in the range of $25M$50M

Section iconFunding & Financials

  • $13M

    Nabsys has raised a total of $13M of funding over 9 rounds. Their latest funding round was raised on Nov 09, 2022 in the amount of $13M.

  • $25M$50M

    Nabsys's revenue is estimated to be in the range of $25M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.